The trail will assess EXS-21546 along with anti-PD-1 therapy in relapsed or refractory RCC and NSCLC patients.
Trialmap helps participants to view data on the trial and receive reminders for appointments.
Only around two in three individuals with schizophrenia are diagnosed by a physician, likely due to misdiagnosis of the condition.
The blood thinning therapy caused major bleeding that led to the discontinuation of the treatment in these patients.
The project is based on a technology platform and comprises 27 partners from 17 EU and non-EU Member States.
Get industry leading news, data and analysis delivered to your inbox
The trial will assess the safety and efficacy of Diamyd in recently diagnosed type 1 diabetes patients.
Anticipated to enrol ten to 20 subjects, the trial will be carried out at the U of A.
The trial is anticipated to commence in the first half of next year.